Aio-studien-ggmbh

This phase 2 trial tested a new chemotherapy combination (Nal-IRI with 5-FU and leucovorin) against a standard treatment (gemcitabine plus cisplatin) in 93 people with advanced biliary tract cancer that could not be removed by surgery. The study aimed to see which approach better…

This study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy (carboplatin and etoposide) is safe and effective for people with extensive-stage small cell lung cancer who have poor performance status (ECOG 2). The trial enrolled 70 participants and…

This study tested a combination of three drugs (encorafenib, binimetinib, and cetuximab) given before surgery to people with a specific type of colorectal cancer that has a BRAF V600E mutation. Only 2 patients took part. The goal was to see how much the tumor shrank and to check …